FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Sees Significant Increase in Short Interest

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 18,402 shares, an increase of 855.5% from the July 15th total of 1,926 shares. Based on an average daily volume of 7,799 shares, the short-interest ratio is presently 2.4 days. Currently, 0.2% of the company’s shares are sold short.

FT Vest U.S. Equity Deep Buffer ETF – October Stock Performance

Shares of BATS:DOCT remained flat at $47.49 during trading on Tuesday. The stock had a trading volume of 4,850 shares, compared to its average volume of 11,738. The company has a market cap of $390.84 million, a PE ratio of 24.90 and a beta of 0.37. FT Vest U.S. Equity Deep Buffer ETF – October has a 1-year low of $41.80 and a 1-year high of $48.42. The stock has a 50 day moving average price of $46.72 and a two-hundred day moving average price of $45.47.

Institutional Trading of FT Vest U.S. Equity Deep Buffer ETF – October

An institutional investor recently raised its position in FT Vest U.S. Equity Deep Buffer ETF – October stock. Winnow Wealth LLC raised its position in shares of FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) by 4,725.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 121,993 shares of the company’s stock after acquiring an additional 119,465 shares during the period. FT Vest U.S. Equity Deep Buffer ETF – October makes up about 4.1% of Winnow Wealth LLC’s investment portfolio, making the stock its 5th largest position. Winnow Wealth LLC owned 1.48% of FT Vest U.S. Equity Deep Buffer ETF – October worth $5,490,000 at the end of the most recent reporting period.

About FT Vest U.S. Equity Deep Buffer ETF – October

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.